A detailed history of Campbell & CO Investment Adviser LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 11,026 shares of RDY stock, worth $152,379. This represents 0.07% of its overall portfolio holdings.

Number of Shares
11,026
Previous 3,383 225.92%
Holding current value
$152,379
Previous $257,000 240.86%
% of portfolio
0.07%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$75.41 - $84.21 $576,358 - $643,617
7,643 Added 225.92%
11,026 $876,000
Q2 2024

Aug 13, 2024

SELL
$68.26 - $76.19 $310,378 - $346,435
-4,547 Reduced 57.34%
3,383 $257,000
Q1 2024

May 10, 2024

BUY
$67.36 - $77.59 $534,164 - $615,288
7,930 New
7,930 $581,000
Q3 2023

Nov 08, 2023

BUY
$61.9 - $72.77 $807,733 - $949,575
13,049 New
13,049 $872,000
Q2 2022

Aug 09, 2022

SELL
$49.62 - $58.13 $184,685 - $216,359
-3,722 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$48.27 - $65.25 $179,660 - $242,860
3,722 New
3,722 $207,000
Q3 2020

Oct 15, 2020

SELL
$51.39 - $72.41 $202,733 - $285,657
-3,945 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$39.55 - $54.65 $156,024 - $215,594
3,945 New
3,945 $209,000
Q3 2018

Nov 08, 2018

SELL
$29.25 - $36.73 $366,473 - $460,190
-12,529 Closed
0 $0
Q2 2018

Jul 13, 2018

BUY
$28.49 - $35.06 $356,951 - $439,266
12,529 New
12,529 $403,000
Q1 2018

May 04, 2018

SELL
$31.93 - $39.54 $275,779 - $341,506
-8,637 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$34.15 - $37.62 $294,953 - $324,923
8,637
8,637 $324,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.29B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.